2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights

References

• Peng CK, Zeng T, Xu XJ, et al. Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors. Eur J Med Chem 2017;127:187–99.
   PubMed Web of Science ®Google Scholar
• Mohassab AM, Hassan HA, Abdelhamid D, et al. Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases. Bioorg Chem 2021;106:104510.
   PubMed Web of Science ®Google Scholar
• Kovvuri J, Nagaraju B, Nayak VL, et al. Design, synthesis and biological evaluation of new β-carboline-bisindole compounds as DNA binding, photocleavage agents and topoisomerase I inhibitors. Eur J Med Chem 2018;143:1563–77.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–49.
   PubMed Web of Science ®Google Scholar
• Khodair AI, Elbadawi MM, Elsaady MT, Abdellatif KRA. Design, synthesis, molecular docking and cytotoxicity evaluation of some novel 5-arylidene-3-(substituted phenyl)-2-(p-tolylamino)-4-imidazolones. J Appl Pharm Sci 2017;7:58–68.
   Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Xie H, Lin X, Zhang Y, et al. Design, synthesis and biological evaluation of ring-fused pyrazoloamino pyridine/pyrimidine derivatives as potential FAK inhibitors. Bioorganic Med Chem Lett 2020;30:127459.
   PubMedGoogle Scholar
• Elbadawi MM, Eldehna WM, Nocentini A, et al. Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: synthesis and evaluation of the carbonic anhydrase inhibitory activities. Eur J Med Chem 2021;218:113360.
   PubMed Web of Science ®Google Scholar
• Abdellatif KRA, Elbadawi MM, Elsaady MT, et al. Design, synthesis and cytotoxicity evaluation of new 3, 5-disubstituted-2-thioxoimidazolidinones. Anticancer Agents Med Chem 2018;18:573–82.
   PubMed Web of Science ®Google Scholar
• Ismail RSM, Abou-Seri SM, Eldehna WM, et al. Novel series of 6-(2-substitutedacetamido)-4-anilinoquinazolines as EGFR-ERK signal transduction inhibitors in MCF-7 breast cancer cells. Eur J Med Chem 2018;155:782–96.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wu X, Wang L, et al. Facile and efficient synthesis and biological evaluation of 4-anilinoquinazoline derivatives as EGFR inhibitors. Bioorg Med Chem Lett 2016;26:2589–93.
   PubMedGoogle Scholar
• Hu S, Xie G, Zhang DX, et al. Synthesis and biological evaluation of crown ether fused quinazoline analogues as potent EGFR inhibitors. Bioorg Med Chem Lett 2012;22:6301–5.
   PubMed Web of Science ®Google Scholar
• Dawson JC, Serrels A, Stupack DG, et al. Targeting FAK in anticancer combination therapies. Nat Rev Cancer 2021;21:313–24.
   PubMed Web of Science ®Google Scholar
• Dao P, Jarray R, Coq JL, et al. Synthesis of novel diarylamino-1,3,5-triazine derivatives as FAK inhibitors with anti-angiogenic activity. Bioorg Med Chem Lett 2013;23:4552–6.
   PubMed Web of Science ®Google Scholar
• Wang R, Zhao X, Yu S, et al. Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: design, synthesis, biological evaluation and molecular docking study. Bioorg Chem 2020;102:104092.
   PubMed Web of Science ®Google Scholar
• Li B, Li Y, Tomkiewicz-Raulet C, et al. Design, synthesis, and biological evaluation of covalent inhibitors of focal adhesion kinase (FAK) against human malignant glioblastoma. J Med Chem 2020;63:12707–24.
   PubMed Web of Science ®Google Scholar
• Gavriil ES, Doukatas A, Karampelas T, et al. Design, synthesis and biological evaluation of novel substituted purine isosters as EGFR kinase inhibitors, with promising pharmacokinetic profile and in vivo efficacy. Eur J Med Chem 2019;176:393–409.
   PubMed Web of Science ®Google Scholar
• McLean GW, Carragher NO, Avizienyte E, et al. The role of focal-adhesion kinase in cancer – a new therapeutic opportunity. Nat Rev Cancer 2005;5:505–15.
   PubMed Web of Science ®Google Scholar
• Luo QY, Zhou SN, Pan WT, et al. A multi-kinase inhibitor APG-2449 enhances the antitumor effect of ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition. Biochem Pharmacol 2021;183:114318.
   PubMed Web of Science ®Google Scholar
• Ai M, Wang C, Tang Z, et al. Design and synthesis of diphenylpyrimidine derivatives (DPPYs) as potential dual EGFR T790M and FAK inhibitors against a diverse range of cancer cell lines. Bioorg Chem 2020;94:103408.
   PubMed Web of Science ®Google Scholar
• Eke I, Cordes N. Dual targeting of EGFR and focal adhesion kinase in 3D grown HNSCC cell cultures. Radiother Oncol 2011;99:279–86.
   PubMed Web of Science ®Google Scholar
• Yadav P, Shah K. Quinolines, a perpetual, multipurpose scaffold in medicinal chemistry. Bioorg Chem 2021;109:104639.
   PubMed Web of Science ®Google Scholar
• Karnik KS, Sarkate AP, Tiwari SV, et al. Computational and synthetic approach with biological evaluation of substituted quinoline derivatives as small molecule L858R/T790M/C797S triple mutant EGFR inhibitors targeting resistance in non-small cell lung cancer (NSCLC). Bioorg Chem 2021;107:104612.
   PubMed Web of Science ®Google Scholar
• Matada BS, Pattanashettar R, Yernale NG. A comprehensive review on the biological interest of quinoline and its derivatives. Bioorg Med Chem 2021;32:115973.
   PubMed Web of Science ®Google Scholar
• Weyesa A, Mulugeta E. Recent advances in the synthesis of biologically and pharmaceutically active quinoline and its analogues: a review. RSC Adv 2020;10:20784–93.
   PubMed Web of Science ®Google Scholar
• Afzal O, Kumar S, Haider MR, et al. A review on anticancer potential of bioactive heterocycle quinoline. Eur J Med Chem 2015;97:871–910.
   PubMed Web of Science ®Google Scholar
• Wu P, Nielsen TE, Clausen MH. FDA-approved small-molecule kinase inhibitors. Trends Pharmacol Sci 2015;36:422–39.
   PubMed Web of Science ®Google Scholar
• He R, Xu B, Ping L, Lv X. Structural optimization towards promising β-methyl-4-acrylamido quinoline derivatives as PI3K/mTOR dual inhibitors for anti-cancer therapy: The in vitro and in vivo biological evaluation. Eur J Med Chem 2021;214:113249.
   PubMed Web of Science ®Google Scholar
• Nan X, Li HJ, Fang SB, et al. Structure-based discovery of novel 4-(2-fluorophenoxy)quinoline derivatives as c-Met inhibitors using isocyanide-involved multicomponent reactions. Eur J Med Chem 2020;193:112241.
   PubMed Web of Science ®Google Scholar
• Li K, Li Y, Zhou D, et al. Synthesis and biological evaluation of quinoline derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors. Bioorg Med Chem 2016;24:1889–97.
   PubMed Web of Science ®Google Scholar
• Pannala M, Kher S, Wilson N, et al. Synthesis and structure-activity relationship of 4-(2-aryl-cyclopropylamino)-quinoline-3-carbonitriles as EGFR tyrosine kinase inhibitors. Bioorg Med Chem Lett 2007;17:5978–82.
   PubMed Web of Science ®Google Scholar
• Pawar VG, Sos ML, Rode HB, et al. Synthesis and biological evaluation of 4-anilinoquinolines as potent inhibitors of epidermal growth factor receptor. J Med Chem 2010;53:2892–901.
   PubMed Web of Science ®Google Scholar
• Li S, Hu L, Li J, et al. Design, synthesis, structure-activity relationships and mechanism of action of new quinoline derivatives as potential antitumor agents. Eur J Med Chem 2019;162:666–78.
   PubMed Web of Science ®Google Scholar
• Abouzid K, Shouman S. Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase. Bioorg Med Chem 2008;16:7543–51.
   PubMed Web of Science ®Google Scholar
• Tsou HR, Overbeek-Klumpers EG, Hallett WA, et al. Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity. J Med Chem 2005;48:1107–31.
   PubMed Web of Science ®Google Scholar
• Elbadawi MM, Eldehna WM, Wang W, et al. Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity. Eur J Med Chem 2021;215:113261.
   PubMed Web of Science ®Google Scholar
• Pommier Y. Drugging topoisomerases: lessons and challenges. ACS Chem Biol 2013;8:82–95.
   PubMed Web of Science ®Google Scholar
• Marzi L, Agama K, Murai J, et al. Novel fluoroindenoisoquinoline non-camptothecin topoisomerase I inhibitors. Mol Cancer Ther 2018;17:1694–704.
   PubMed Web of Science ®Google Scholar
• Dexheimer TS, Pommier Y. DNA cleavage assay for the identification of topoisomerase I inhibitors. Nat Protoc 2008;3:1736–50.
   PubMed Web of Science ®Google Scholar
• Antony S, Jayaraman M, Laco G, et al. Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I. Cancer Res 2003;63:7428–35.
   PubMed Web of Science ®Google Scholar
• Elsayed MSA, Su Y, Wang P, et al. Design and synthesis of chlorinated and fluorinated 7-azaindenoisoquinolines as potent cytotoxic anticancer agents that inhibit topoisomerase I. J Med Chem 2017;60:5364–76.
   PubMed Web of Science ®Google Scholar
• Bell EW, Zhang Y. DockRMSD: an open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism. J Cheminform 2019;11:1–9.
   PubMed Web of Science ®Google Scholar
• Waterhouse A, Bertoni M, Bienert S, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 2018;46:W296–303.
   PubMed Web of Science ®Google Scholar
• Zhao S, hong He Y, Wu D, Guan Z. A new general approach to 4-substituted-3-halo-2-quinolones. J Fluor Chem 2010;131:597–605.
   Web of Science ®Google Scholar
• Butin AV, Smirnov SK, Stroganova TA, et al. Simple route to 3-(2-indolyl)-1-propanones via a furan recyclization reaction. Tetrahedron 2007;63:474–91.
   Web of Science ®Google Scholar
• Huang Z, Yang Y, Xiao Q, et al. Auto-tandem catalysis: synthesis of acridines by Pd-catalyzed C=C bond formation and C(sp2)-N cross-coupling. Eur J Org Chem 2012;2012:6586–93.
   Web of Science ®Google Scholar
• Mamidala R, Subramani MS, Samser S, et al. Chemoselective alkylation of aminoacetophenones with alcohols by using a palladacycle-phosphine catalyst. Eur J Org Chem 2018;2018:6286–96.
   Web of Science ®Google Scholar
• Hanwell MD, Curtis DE, Lonie DC, et al. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminform 2012;4:17.
   PubMed Web of Science ®Google Scholar
• Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol 2015;1263:243–50.
   PubMedGoogle Scholar
• Protein data bank, n.d. Available from: https://www.rcsb.org/
   Google Scholar
• Trott O, Olson AJ. Software news and update AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010;31:455–61.
   PubMed Web of Science ®Google Scholar
• The PyMOL molecular graphics system, n.d.
   Google Scholar
• Abraham MJ, Murtola T, Schulz R, et al. Gromacs: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 2015;1–2:19–25.
   Google Scholar
• Said MA, Albohy A, Abdelrahman MA, Ibrahim HS. Importance of glutamine 189 flexibility in SARS-CoV-2 main protease: lesson learned from in silico virtual screening of ChEMBL database and molecular dynamics. Eur J Pharm Sci 2021;160:105744.
   PubMed Web of Science ®Google Scholar
• Zoete V, Cuendet MA, Grosdidier A, Michielin O. SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem 2011;32:2359–68.
   PubMed Web of Science ®Google Scholar
• Huang J, Mackerell AD. CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J Comput Chem 2013;34:2135–45.
   PubMed Web of Science ®Google Scholar
• Mark P, Nilsson L. Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. J Phys Chem A 2001;105:9954–60.
   Web of Science ®Google Scholar
• Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys 2007;126:014101.
   PubMed Web of Science ®Google Scholar
• Parrinello M, Rahman A. Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys 1981;52:7182–90.
   Web of Science ®Google Scholar
• Hess B, Bekker H, Berendsen HJC, Fraaije JGEM. LINCS: a linear constraint solver for molecular simulations. J Comput Chem 1997;18:1463–72.
   Web of Science ®Google Scholar
• Darden T, York D, Pedersen L. Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems. J Chem Phys 1993;98:10089–92.
   Web of Science ®Google Scholar